- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr David R. Stukus Spotlights Unmet Needs in Atopic Dermatitis Management
David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, speaks on the lack of interventions to manage the underlying causes of exacerbation in atopic dermatitis.
There remains significant unmet needs in addressing the underlying causes of atopic dermatitis, said David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology.
Transcript
What are some of the unmet needs in atopic dermatitis? Do you think that these newer therapies will help or does more need to be done?
Right now, a lot of what we do is sort of like putting band-aids, literally, on some of our patients with the terrible skin that they have, and this really can decrease quality of life. In addition to the severe itch that can occur, the skin can undergo long-term damage and it can lead to decreased work and just the ability to do things that people love.
Imagine having terrible eczema affecting your hands and it decreases your ability to do crafting, woodworking, or whatever you want to do, what your passion is. So, we need better options that really treat the underlying sort of causes of atopic dermatitis. And I think that's where we're headed with these wonderful, exciting treatment options. So, that's really the biggest unmet need right now.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
